Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose allopurinol versus allopurinol plus probenecid for poorly controlled gout
ACTRN12612000987864Phase 4Terminated
- Sponsor
- Tauranga Hospital
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of allopurinol and probenecid in gout (2 arms), sponsored by Tauranga Hospital. Primary endpoint: Comparison of serum uric acid levels. Started Dec 2012; status: terminated.
02
Drugs
allopurinolprobenecid
03
Conditions
gout
Beyond the preview
Go deeper on ACTRN12612000987864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000987864.